What is Hyaluronic Acid Based Dermal Fillers Market Scope?
The market is expected to be powered by rising demand for youthful and flawless skin through noninvasive and outpatient cosmetic dermatology techniques. Furthermore, the industry is projected to benefit from an increase in medical tourism for cosmetic procedures. Dermal fillers based on hyaluronic acid can be used to smooth wrinkles and fine lines, produce fuller and more accentuated lips, and add volume and contour to the face. Furthermore, dermal fillers based on hyaluronic acid are gaining popularity for the correction of facial structure and form.
The Hyaluronic Acid Based Dermal Fillers market study is being classified by Type (Single-phase product and Duplex products), by Application (Bootlegging, Sculpting, Fill Scars and Others) and major geographies with country level break-up.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Hyaluronic Acid Based Dermal Fillers market throughout the predicted period.
Medicis Aesthetics Holdings, Inc. (United States), Allergan PLC (Ireland), Galderma S.A. (Switzerland), Merz Pharma GmbH & Co. KGaA (Germany), Genzyme Corporation (United States), Inamed Corporation (United States), Anika Therapeutics, Inc (United States), Sinclair Pharma (United Kingdom), LG Life Sciences, LTD (South Korea), Bio plus Co. Ltd. (United States) and Sculpt Luxury Dermal Fillers Ltd (Czechia) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Bioxis Pharmaceutical (France), Laboratories Vivacy (France) and Bohus Biotech AB (Sweden).
Analyst at AMA have segmented the market study of Global Hyaluronic Acid Based Dermal Fillers market by Type, Application and Region.
On the basis of geography, the market of Hyaluronic Acid Based Dermal Fillers has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
In Nov 2018, Galderma Laboratories, L.P. announced that it has received U.S. Food and Drug Administration (FDA) approval for the use of Restylane Lyft®, a hyaluronic acid (HA) dermal filler, with a small blunt tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21.1 A small blunt tip cannula is a thin, flexible tube with a small opening on the side that provides an effective means for delivering fillers.
In Aug 2020, Revance Therapeutics, Inc. announced that the company’s field force is established and will begin introducing its prestige aesthetics portfolio, including the RHA® Collection of dermal fillers, resilient hyaluronic acid, and the HintMD financial technology (fintech) platform, in the United States (U.S.) in September.
FDA has approved dermal fillers made from absorbable or temporary material can be used to correct moderate to severe facial wrinkles. While the non-absorbable material is allowed for correction of nasolabial folds and cheek acne scars in patients over the age of 21 years. Also, FDA has approved the use of dermal filler for purpose such as hand augmentation. However, the regulatory agency bars dermal filler from being used in breast augmentation, increasing size of the buttocks, increasing fullness of the feet, and implant into bone, tendon, ligament or muscle.
Influencing Market Trend
- Growth in Single-phase Hyaluronic Acid Dermal Fillers
- Increasing Geriatric Population
- Growing Demand for Anti-aging Solutions and Minimally Invasive Aesthetic Treatment
- Growing Applications in Regenerative Medicine and Tissue Engineering
- Increasing R&D Investments for New Hyaluronic Acid Based Dermal Fillers
- Increasing Number of Cosmetic Surgeries Worldwide
- High Cost and Side Effects associated with Hyaluronic Acid Cycles
- Lack of Skilled Professionals
Key Target Audience
Hyaluronic Acid Based Dermal Fillers Providers, New Entrants/Investors, Analysts and Strategic Business Planners, Government Regulatory and Research Organizations, End-Use Industry, Healthcare Industries, Research Institutes and Others
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.